Genetic diversity, transmission dynamics and drug resistance of Mycobacterium tuberculosis in Angola
Open Access
- 23 February 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 42814
Abstract
Tuberculosis (TB) poses a serious public health problem in Angola. No surveillance data on drug resistance is available and nothing is known regarding the genetic diversity and population structure of circulating Mycobacterium tuberculosis strains. Here, we have genotyped and evaluated drug susceptibility of 89 Mycobacterium tuberculosis clinical isolates from Luanda. Thirty-three different spoligotype profiles corresponding to 24 different Shared International Types (SIT) and 9 orphan profiles were detected. SIT 20 (LAM1) was the most prevalent (n = 16, 18.2%) followed by SIT 42 (LAM9; n = 15, 17.1%). Overall, the M. tuberculosis population structure in this sample was dominated by LAM (64.8%) and T (33.0%) strains. Twenty-four-loci MIRU-VNTR analysis revealed that a total of 13 isolates were grouped in 5 distinct clusters. Drug susceptibility data showed that 22 (24.7%) of the 89 clinical isolates were resistant to one or more antibacillary drugs of which 4 (4.5%) were multidrug resistant. In conclusion, this study demonstrates a high predominance of LAM strains circulating in the Luanda setting and the presence of recent transmission events. The rate and the emergence dynamics of drug resistant TB found in this sample are significant and highlight the need of further studies specifically focused on MDR-TB transmission.Keywords
This publication has 30 references indexed in Scilit:
- SITVITWEB – A publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiologyInfection, Genetics and Evolution, 2012
- Diversity of Mycobacterium tuberculosis genotypes circulating in Ndola, ZambiaBMC Infectious Diseases, 2010
- Follow-Up of Patients with Multidrug Resistant Tuberculosis Four Years after Standardized First-Line Drug TreatmentPLOS ONE, 2010
- MIRU-VNTRplus: a web tool for polyphasic genotyping of Mycobacterium tuberculosis complex bacteriaNucleic Acids Research, 2010
- Low Occurrence of Tuberculosis Drug Resistance among Pulmonary Tuberculosis Patients from an Urban Setting, with a Long-Running DOTS Program in ZambiaTuberculosis Research and Treatment, 2010
- The Influence of Host and Bacterial Genotype on the Development of Disseminated Disease with Mycobacterium tuberculosisPLOS Pathogens, 2008
- High genetic diversity among Mycobacterium tuberculosis complex strains from Sierra LeoneBMC Microbiology, 2008
- Proposal for Standardization of Optimized Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Typing ofMycobacterium tuberculosisJournal of Clinical Microbiology, 2006
- Tuberculosis Recurrence and Mortality after Successful Treatment: Impact of Drug ResistancePLOS Medicine, 2006
- The Epidemiology of Tuberculosis in San Francisco -- A Population-Based Study Using Conventional and Molecular MethodsNew England Journal of Medicine, 1994